Friday, July 11, 2014 12:55:28 AM
"Updates every 30-60 days". Show us where that promise was made.
No updates ???? Clearly there is some disconnect on what an update is. I also haven't seen a PR that repeats itself with the same BS.
"The bovine study should be done by now"? Based on what information do you know that to be the case ? HEPI hasn't offered a timeframe for completion of the study and ultimately ZOETIS WOULD DICTATE WHEN/IF THE STUDY RESULT IS SUFFICIENT ENOUGH TO MAKE A DECISION ON WHETHER OR NOT TO LICENSE ...... NOT HEPI. The study is a requirement for Zoetis. Not HEPI. HEPI offered an expectation to report a subset of preliminary results in May. This would be an expectation the company created and has not delivered on thus far. Does it make it a lie ??? If you wanna call it that, so be it. Dahl's track record thus far is to deliver results. Results are rarely provided in the timeframe he himself offers. But to his credit, he eventually delivers. A stark contrast to former mgmt. I do agree preliminary bovine results should be known by now and should be offered but no one can say the "study should be done by now". Zero basis from which to make that claim. All one has to do is read the Dairy Experts PR to see there is significant complexity and staggering of study tests. The March 31 investor update says preliminary results on select groups in two months time. If the study began April 24 when it was PRd, 2 months is two weeks ago for PRELIMINARY result.
If an investor does not know where HEPI is heading by now, I don't know what the company could say that would articulate that beyond what Dahl has stated in the last two shareholder letters along with the information on the website and the PRs on the research. Its all spelled out. Also if one cannot distinguish between former and current mgmt, it is crystal clear owning this stock should be reconsidered.
So does making up lies to prove the assertion of lies prove anything ?? I think not. IMO any serious investor can make a few calls ..... without even talking to HEPI ..... To confirm if this is real. It is ultra clear that hasn't happened here.
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM